Baird Capital Portfolio Company Veniti Enters Global Distribution Agreement

Baird Capital portfolio company Veniti, a California and St.Louis-based leader in the advancement of treatment for deep venous disease, announced today that Boston Scientific will distribute the VICI VENOUS STENT under a limited global distribution agreement. This deal will expand Veniti's presence globally, as the VICI VENOUS STENT has gained wide market acceptance for the unique balance of end-to-end strength, flexibility and lumen quality for addressing the challenging requirements of venous disorders.

For more information, please read Veniti's news release.